A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.

NCT00717821 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: Methoxy Polyethylene Glycol-epoetin Beta
DRUG: Epoetin Beta
DRUG: Darbepoetin Alfa

Sponsor

Hoffmann-La Roche